Alan Bradley

Alan Bradley

Grundare på
Kymab Group Ltd.
66 år
Health Technology
Consumer Services
Finance

Profil

Allan Bradley is the founder of Spectral Genomics, Inc., founded in 2000.
Dr. Bradley is the founder of ExpressionEdits Ltd., founded in 2021.
Dr. Bradley is the founder of T-Therapeutics Ltd., founded in 2022, and holds the title Chief Scientific Officer & Director since 2025.
Dr. Bradley is also the founder of Lexicon Pharmaceuticals, Inc.,Kymab Group Ltd...
Dr. Bradley is an Independent Director at Sieger Healthcare Acquisition Corp.
Dr. Bradley is a Professor at the University of Cambridge.
Dr. Bradley was Executive Director at Wellcome Trust Sanger Institute.
Dr. Bradley was Professor at Baylor College of Medicine.
Dr. Bradley completed undergraduate, graduate, and doctorate degrees at the University of Cambridge.

Aktiva positioner av Alan Bradley

FöretagPositionStart
Direktör/Styrelseledamot -
Grundare -
Företagsledare/Principal -

Tidigare kända positioner av Alan Bradley

FöretagPositionSlut
Grundare -
Företagsledare/Principal -
LEXICON PHARMACEUTICALS, INC. Grundare -
Direktör/Styrelseledamot -
Grundare -
Se detaljerna i Alan Bradleys erfarenhet

Alan Bradleys utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

91

Första gradens relationer

8

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag8

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Finance

Commercial Services

  1. Börsen
  2. Insiders
  3. Alan Bradley